RWPA
CVS icon

Richard W. Paul & Associates’s CVS Health CVS Stock Holding History

Richard W. Paul & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
14,594
+84
+0.6% +$7.5K 0.46% 54
2026
Q1 		$1.04M Buy
14,510
+503
+4% +$38.7K 0.35% 82
2025
Q4 		$1.11M Sell
14,007
-1,288
-8% -$102K 0.37% 71
2025
Q3 		$1.15M Sell
15,295
-615
-4% -$42.1K 0.39% 64
2025
Q2 		$1.1M Sell
15,910
-182
-1% -$11.9K 0.4% 64
2025
Q1 		$1.09M Sell
16,092
-435
-3% -$26K 0.43% 52
2024
Q4 		$742K Buy
16,527
+1,305
+9% +$73.2K 0.27% 99
2024
Q3 		$957K Buy
15,222
+733
+5% +$42.8K 0.34% 80
2024
Q2 		$856K Buy
14,489
+14,456
+43,806% +$904K 0.33% 83
2024
Q1 		$2.63K Hold
33
– – ﹤0.01% 406
2023
Q4 		$2.61K Sell
33
-95
-74% -$6.76K ﹤0.01% 395
2023
Q3 		$8.94K Hold
128
– – ﹤0.01% 298
2023
Q2 		$8.85K Hold
128
– – ﹤0.01% 323
2023
Q1 		$9.51K Sell
128
-4,075
-97% -$342K ﹤0.01% 325
2022
Q4 		$392K Buy
+4,203
New +$406K 0.2% 113

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Richard W. Paul & Associates's CVS Position: Q2 2026 in Review

Richard W. Paul & Associates increased its CVS Health (CVS) stake by 0.58% in Q2 2026, buying an estimated $7.5K and bringing the position to 14,594 shares worth $1.51M. The position accounts for 0.46% of the portfolio, ranked #54.

Richard W. Paul & Associates first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Richard W. Paul & Associates held 14,594 shares of CVS Health worth $1.51M as of Q2 2026.
  • Richard W. Paul & Associates bought 84 CVS Health shares in Q2 2026, an estimated $7.5K.
  • CVS Health made up 0.46% of Richard W. Paul & Associates's portfolio in Q2 2026, its #54 holding.
  • Richard W. Paul & Associates first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Richard W. Paul & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.